dabigatran has been researched along with factor f430 in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (factor f430) | Trials (factor f430) | Recent Studies (post-2010) (factor f430) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 67 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aakjaer, M; Andersen, M; Ballarin, E; De Bruin, ML; Droz, C; Gardarsdottir, H; Gasse, C; Groenwold, R; Heeke, A; Huerta, C; Ibáñez, L; Klungel, O; Lassalle, R; Leon-Muñoz, LM; Martin Merino, E; Montero, D; Moore, N; Rottenkolber, M; Sabaté, M; Schmiedl, S; Souverein, P; van den Ham, HA; Vidal, X | 1 |
1 other study(ies) available for dabigatran and factor f430
| Article | Year |
|---|---|
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Denmark; Dose-Response Relationship, Drug; Drug Interactions; Drug Utilization; Female; France; Germany; Humans; Longitudinal Studies; Male; Metalloporphyrins; Middle Aged; Netherlands; Pyrazoles; Pyridones; Rivaroxaban; Sex Factors; Spain; United Kingdom; Young Adult | 2019 |